MS News & Perspectives

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how eating a ketogenic diet — low in carbohydrates and high in fats — led to less fatigue and depression for people with relapsing-remitting MS. He also reads “An Accessible Cruise With Family, Canes, and a Scooter Was a Breeze”, a column by Ed Tobias. ===================================== Are you in...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Tysabri given every six weeks was found as effective as the standard dosing at stopping nervous system damage in RRMS patients. He also reads “Recovering My Self-esteem After Adapting to MS-related Incontinence”, from Beth Ullah's, regular column "Through the Looking Glass." =================================== Are...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how MS affects all aspects of life, from physical and mental health to relationships and hobbies, according to results from a U.K. online survey. He also reads "Remembering My First MS Symptom”, from Ed Tobias' column, "The MS Wire." =================================== Are you interested in learning more...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads an article about the portable neuromodulation stimulator (PoNS) device that was approved by the FDA last year to help treat multiple sclerosis gait problems. He also reads “The MSer Who Lay in Bed for 2 Years and Can Now Walk Again”, a column by John Connor. =================================== Are you interested in learni...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how blood levels of neurofilament light chain (NfL) helped predict disease progression in multiple sclerosis patients in a Phase 3 trial. He also reads “MS News That Caught My Eye Last Week: Bone Marrow Infusions, ATA188, Enhanced MRIs, Costs”, a column by Ed Tobias. =================================...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a blood test for the multiple sclerosis biomarker, neurofilament light chain, has been granted breakthrough device designation by the FDA. He also reads “The Tricks of Intermittent Catheterization When You’re in a Wheelchair” a column by John Connor. =================================== Are you interested in learn...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a trial will test an antihistamine in combination with the diabetes medicine metformin as a way to repair the myelin sheath. He also reads the column by Ed Tobias, The MS Wire, “The High Cost of Living With MS”. =================================== Are you interested in learning more about multiple sclerosis? If s...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how four active progressive MS patients safely underwent a second harvesting and infusion of bone marrow cells in a safety, proof-of-concept trial. He also reads “Pain and Positivity: My Experience With Plasmapheresis,” a column by Beth Ullah.

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a Phase 1/2 clinical trial has begun dosing with IMCY-0141, Imcyse’s targeted immunotherapy to slow progression of relapsing-remitting MS. He also reads “MS News That Caught My Eye Last Week: Deep Brain Stimulation, IMCY-0141, Foralumab, Vumerity,” a column by Ed Tobias. =========================...

Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. Dr. Beaber is also the author of Resilience in the Face of Multiple Sclerosis, where he shares examples of people who have made great strides and life pivots despite their degenerative conditions. Listen as they discuss why multiple sclerosis...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Atara may open two Phase 3 clinical trials of ATA188, an immunotherapy targeting EBV-infected B-cells in non-active progressive MS patients. He also reads “Upon Reflection, I’m Determined to Seize the Day” from "The MS Wire," a column by Ed Tobias. =================================== Are you interested in learnin...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how symptoms of Sjögren’s syndrome, including dry eyes and mouth, were observed among 16 people with multiple sclerosis. He also reads “‘Top Gear’: Unfortunately, I’m a Backward-leaning Jeremy Clarkson”, a column by John Connor. =================================== Are you interested in learning more about multiple scl...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291, an experimental therapy to promote nervous system repair, has been well-tolerated in an ongoing Phase 1 study in healthy volunteers. He also reads the latest MS News Today’s Expert Voices article. In this instalment, Annie Brewster, MD, who also has MS, shares her tips on how to improve patient-provider...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how the FDA has cleared eight more SPMS patients for treatment with foralumab nasal spray, under a special access program. He also reads “Crossing the Lemtrada Finish Line”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, ple...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS for up to 2.5 years. He also reads “There’s No Such Thing as Perfect”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? If so,...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how 75% of SPMS and PPMS patients in the CONSONANCE trial showed no evidence of disease progression after a year of Ocrevus treatment. He also reads “Old Friends, Broken Chairs, UTI Admissions, and Redemption”, a column by John Connor. =================================== Are you interested in learnin...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a questionnaire tailored for women with multiple sclerosis may help them talk to their doctor about their sexual health. He also reads “The Building Blocks of Becoming a Busy Bee”, a column by Beth Ullah. =================================== Are you interested in learning more about multiple sclerosis? If so, plea...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how infection with the herpes simplex virus does not increase the risk of multiple sclerosis, according to a new analysis based on genetic data. He also reads the news article, “Artist With MS Finds Beauty, Individuality in MRI Brain Scans”. =================================== Are you interested in l...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the National Multiple Sclerosis Society detailed its Pathways to Cures Roadmap and ways to advance each pathway, with the goal to end MS. He also reads an article from MS News Today’s "Expert Voices", where Kassandra Munger explores research about the connection between vitamin D levels and MS, and shares her adv...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how researchers have discovered the key to bypassing the blood-brain barrier, which may lead to the development of more targeted MS treatments. He also reads “Dry Glaucomflecken and Other Healthcare Jokers” from Ed Tobias' column, "The MS Wire". =================================== Are you interested in lear...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how cannabis-based medications could ease muscle spasms, decrease pain, and aid in sleep for people with MS. He also reads “The Heel that Won’t Heal”, by John Connor, from his column "Fall Down, Get Up Again". =================================== Are you interested in learning more about multiple sclerosi...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how a four-protein complex of the protein STAT5 could be involved in the development of MS-like autoimmune disease in mice. He also reads “One Month of MS Awareness Isn’t Enough”, from Ed Tobias' column, "The MS Wire". =================================== Are you interested in learning more about multiple sclerosis? If...

Tim Coetzee is the Chief Advocacy, Services and Science Officer at the National Multiple Sclerosis Society. Tim leads all efforts focused on state and federal advocacy, marketing and communications, services and connection programs. He leads staff for the International Progressive MS Alliance – a global collaboration of MS Societies, scientists, the pharmaceutical industry and people with progress...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a study found no increased risks for women with MS or their babies after exposure to Ocrevus before or during pregnancy. He also reads an article about how autologous hematopoietic stem cell transplant, despite risks, may be a viable treatment option for some MS patients. =================================== Are y...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291 was deemed well tolerated, and is allowing enrolment of a second group of volunteers into its clinical trial. He also reads “The Visible and Invisible Reflections of MS”, from Beth Ullah's column "Through the Looking Glass". =================================== Are you interested in learning more about mul...